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The Need for FDA Regulation of Tobacco Products
Senator Edward M. Kennedy*
Smoking is the number one preventable cause of death in America.
Empowering the Food and Drug Administration (FDA) to regulate tobacco
products is the most important action we can take to substantially reduce
the number of men and women who suffer and die from smoking-induced
disease each year.
We cannot, in good conscience, continue to allow the federal agency
most responsible for protecting the public health to remain powerless to
deal with the enormous risks of tobacco-the most lethal of all consumer
products. That is why Senator Mike DeWine and I introduced legislation
expanding the FDA's jurisdiction to cover tobacco products and why
twenty other senators have already co-sponsored it.' That is also why we are
confident that the Senate will pass legislation granting the FDA the
necessary authority to take on this enormously important task.
The provisions of this bill track the bipartisan compromise on the
terms of FDAjurisdiction that was reached during Senate consideration of
comprehensive tobacco control legislation in 1998. Fifty-eight senators
supported the comprehensive bill at that time. That legislation was never
enacted because of disputes over tobacco taxation and litigation, not over
FDA authority.
The legislation is a fair and balanced approach to FDA regulation. It
creates a new section in FDA jurisdiction for the regulation of tobacco
products, with standards that allow for consideration of the unique issues
raised by tobacco use. It is sensitive to the concerns of tobacco farmers,
small businesses, and nicotine-dependent smokers. Nevertheless, it clearly
gives the FDA the power it needs in order to prevent youth smoking and to
reduce addiction to this highly lethal product. The FDA would be given
broad authority to consider all the relevant factors related to tobacco use,
and to take such action as it determines "is appropriate for the protection
* Senator Edward M. Kennedy is the Ranking Member of the Senate Committee on Health,
Education, Labor, and Pensions, which has jurisdiction over the Department of Health and
Human Services and tobacco issues.
'S. 2626, 107th Cong. (2002).
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of the public health. 2 The agency is expressly directed to analyze the
impact of a proposed rule "with respect to the risks and benefits to the
population as a whole, including users and non-users of the tobacco
product.",
I believe that any attempt to weaken the 1998 language would
undermine the FDA's ability to deal effectively with the enormous health
risks posed by smoking. This concern is shared by a number of
independent public health experts. The bipartisan compromise agreed to
in 1998 is still the best opportunity for senators to come together and grant
the FDA the regulatory authority it needs to substantially reduce the
number of children who start smoking and to help addicted smokers quit.
Nothing less will do the job.
Within the past year, some tobacco companies have even
acknowledged the need for FDA regulation of their products. However,
the proposals presented by the industry and its allies in Congress would
only create a toothless regulatory tiger. While giving the agency nominal
jurisdiction, their legislation would erect serious legal barriers to the FDA's
ability to effectively regulate tobacco products in the public interest. Such a
statute would create a false sense of security amongst smokers and
potential smokers that tobacco products were being made safer to use,
while, in fact, the FDA would be handcuffed in its ability to meaningfully
protect the public. As the legislative debate moves from whether tobacco
products should be regulated by the FDA to what kind of authority the
FDA should have, those who are genuinely concerned with public health
must be vigilant against such industry-inspired ploys.
The stakes are vast. Every day, another five thousand children try their
first cigarette, and two thousand of them become daily smokers. Nearly a
thousand of them will die prematurely from tobacco-induced diseases.
Cigarettes kill well over four hundred thousand Americans each year. That
is more lives lost than from automobile accidents, alcohol abuse, illegal
drugs, AIDS, murder, suicide, and fires combined. Our response to a
public health problem of this magnitude must consist of more than
halfway measures.
We must deal firmly with tobacco company marketing practices that
target children and mislead the public. The FDA needs broad authority to
regulate the sale, distribution, and advertising of cigarettes and smokeless
tobacco. The tobacco industry currently spends over nine billion dollars a
year to promote its products. Much of that money is spent in ways designed
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to tempt children to start smoking, before they are mature enough to
appreciate the enormity of the health risks. The industry knows that more
than ninety percent of smokers start smoking as children and are addicted
by the time they reach adulthood.4
Documents obtained from tobacco companies prove, in the
companies' own words, the magnitude of the industry's efforts to trap
children into dependency on their deadly products. Recent studies by the
Institute of Medicine and the Centers for Disease Control and Prevention
show the substantial role of industry advertising in decisions by young
people to use tobacco products. If we are serious about reducing youth
smoking, the FDA must have the power to prevent industry advertising
designed to appeal to children wherever it will be seen by children. The
proposed legislation will give the FDA the ability to stop tobacco
advertising that glamorizes smoking from appearing where it will be seen
by significant numbers of children.
Contrary to industry claims, the major tobacco companies have not
abandoned their aggressive marketing strategy aimed at children. The
Master Settlement Agreement (MSA) entered into between the major
tobacco companies and forty-six states in 1998 contained an industry
promise not to "take any action, directly or indirectly, to target youth.,
5
Within months of making that commitment, the industry massively
increased the amount it spent on marketing. In 1999, expenditures on
tobacco advertising and promotion rose by 22.3% to $8.24 billion. In 2000,
they rose by an additional 16.2% as cigarette manufacturers spent a record
$9.57 billion on marketing. According to the Federal Trade Commission,
this was the highest level of spending which had ever been reported by the
industry.
Much of the spending increase has been on marketing that is known
to appeal to youths. A March 2002 survey found that while only twenty-
seven percent of adults had seen tobacco advertisements in the preceding
two weeks, sixty-four percent of teenagers recalled seeing tobacco ads
during that period.7 The industry is still promoting cigarettes in the ways
most likely to reach children.
One study documented a twenty-five percent increase in tobacco
advertising in magazines with more than fifteen percent youth readership
4 U.S. DEP'T HEALTH & HUMAN SERVS., PREVENTING TOBACCO USE AMONG YOUNG PEOPLE: A
REPORT or THE SURGEON GENERAL (1994).
'Master Settlement Agreement 15 (1998), available at
http://www.naag.org/issues/tobacco/index.php?smod=919.
6 FED. TRADE COMM'N, CIGARETTE REPORT FOR 2000 (2002).
7 INT'L COMMUNICATIONS REsearch, TEEN EXCEL STUDY FROM MARCH 6-10 2002 (2002).
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in the first year after the MSA was signed." The industry spent $120 million
dollars in the nine-month period covered by the study, most of it
promoting the five brands favored by underage smokers. The following
year, an analysis of advertising penetration found that magazine ads for
fifteen youth-oriented brands of cigarettes reached eighty percent of
children between twelve and seventeen years of age at least seventeen times
during 2000.9 The increased level of tobacco advertising in youth-oriented
magazines following the MSA received a great deal of public attention. The
adverse publicity and the threat of new litigation from state Attorneys
General led several of the major tobacco companies to reduce the level of
magazine advertising. Last year, a California judge fined R.J. Reynolds $20
million for its advertising in youth-oriented magazines, which the court
found to be a violation of the MSA's prohibition on targeting youth.' °
The greatest increases in spending have occurred in the areas of in-
store marketing and promotion, known to be particularly effective in
reaching children. Discount promotions such as "buy one, get one free"
make cigarettes more affordable to kids, who are particularly price
sensitive. Payments to retailers for prime shelf space at children's eye level
make cigarettes more visible to kids in convenience stores. Free
promotional gifts such as hats, jackets, and mini-radios have a strong
appeal for teens. The evidence clearly demonstrates that the tobacco
industry has not given up on its efforts to seduce a new generation of
children into smoking. When one form of marketing to youth becomes too
transparent and controversial, the industry merely moves its dollars to
another, subtler, way of reaching kids. Only a comprehensive set of
enforceable marketing standards developed by the FDA can prevent
continued industry efforts to make nicotine addicts of our children.
The proposed legislation will give the FDA full authority to regulate
tobacco advertising "consistent with and to the full extent permitted by the
First Amendment."" The Supreme Court has repeatedly stated that for
commercial speech to come under the cloak of First Amendment
protection, it must promote lawful activity and not be misleading. There is
a voluminous record of evidence documenting the fact that tobacco
' Diane Turner-Bowker & William L. Hamilton, Cigarette Advertising Expenditures Before and
After the Master Settlement Agreement: Preliminary Findings, at
http://www.tobaccofreekids.org/reports/addicting/magazines/connolly.pdf (May 15,
2000).
9 Charles King & Michael Siegal, The Master Settlement Agreement with the Tobacco Industry and
Cigarette Advertising in Magazines, 345 NEw ENG. J. MED. 504, 504 (2001).
'0 People ex rel. Lockyer v. R.J. Reynolds Tobacco Co., No. GIC 764118, 2002 WL 1292994
(Cal. Super. Ct. June 6, 2002).
" S. 2626, 107th Cong. § 906(d) (2002).
111:1 (2002)
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companies target much of their advertising at children, even though it is
unlawful to sell cigarettes to minors in nearly every state. Tobacco ads
designed to encourage kids to smoke are not promoting a lawful activity.
Much of the industry's advertising is grossly misleading on the critical
health consequences of smoking. Substantial limitations can be
constitutionally imposed on tobacco advertising, as long as the restrictions
are narrowly tailored to prevent these evils.
The FDA's authority must also extend to the sale of tobacco products.
Most states make it illegal to sell cigarettes to children under eighteen, but
surveys show that these laws are rarely enforced and are frequently
violated. The FDA must have the power to limit the sale of cigarettes to
face-to-face transactions in which the age of the purchaser can be verified
by identification. This means an end to self-service displays and most
vending machine sales. There must also be serious enforcement efforts
with real penalties for those caught selling tobacco products to children.
This is the only way to ensure that children under eighteen are not able to
buy cigarettes.
In determining what regulations would most effectively reduce the
number of children who smoke, the FDA conducted the longest
rulemaking proceeding in its history. Seven hundred thousand public
comments were received in the course of that rulemaking. At the
conclusion of its proceeding, the FDA promulgated rules on the manner in
which cigarettes are advertised and sold. Due to litigation, most of those
regulations were never implemented. If we are serious about curbing youth
smoking as much as possible, as soon as possible, it makes no sense to
require the FDA to reinvent the wheel by conducting a new, multi-year
rulemaking process on the same issue. The proposed legislation will give
the youth-access and advertising restrictions already developed by the FDA
the immediate force of law, as if those regulations had been issued under
the new statute. The FDA will have the authority to modify regulations in
future years, as experience and new scientific developments warrant.
The legislation also provides for stronger warnings on all cigarette and
smokeless tobacco packages, as well as in all print advertisements. These
warnings will be more explicit in their description of the medical problems
that can result from tobacco use. The FDA is given the authority to change
the text of these warning labels periodically, to keep their impact strong.
Nicotine in cigarettes is highly addictive. Medical experts say it is as
addictive as heroin or cocaine. Yet, for decades, tobacco companies
vehemently denied the addictiveness of their products. No one can forget
the parade of tobacco executives who testified under oath before Congress
as recently as 1994 that smoking cigarettes is not addictive. Overwhelming
5
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evidence in industry documents, obtained through investigation, proves
that the companies not only knew of the addictive nature of nicotine for
decades, but actually relied on it as the basis for their marketing strategy.
As we now know, cigarette manufacturers chemically manipulated nicotine
in their products to make it even more addictive.
The tobacco industry has a long, dishonorable history of providing
misleading information about the health consequences of smoking. These
companies have repeatedly sought to characterize their products as far less
hazardous than they really are. Furthermore, they made minor innovations
in product design seem far more significant for the health of the user than
they actually were. The FDA must have clear and unambiguous authority to
prevent such misrepresentations in the future. The largest disinformation
campaign in the history of the corporate world must end.
Given the addictiveness of tobacco products, it is essential that the
FDA regulate them for the protection of the public health. Since over forty
million Americans are currently addicted to cigarettes, no responsible
public health official believes that cigarettes should be banned. A ban
would leave those forty million people without a way to satisfy their drug
dependency. The FDA should be able to take the necessary steps to help
addicted smokers overcome their addiction, and to make the product less
toxic for smokers who are unable or unwilling to stop. To do so, the FDA
needs the authority to reduce or remove hazardous ingredients from
cigarettes, to the extent it is scientifically feasible. The inherent risk in
smoking should not be unnecessarily compounded.
Modern cigarettes have become much more than shredded tobacco
rolled in a paper tube; they are highly engineered products, potentially
containing hundreds of ingredients. Some of these ingredients are
inherent in the tobacco leaf, but many are added in manufacturing. For
this reason, the tobacco companies have vigorously opposed ingredient
disclosure. When cigarettes are lit, the burning process actually generates
more than four thousand chemicals in the smoke. Many of them are toxic,
and could be reduced or eliminated if health considerations were given
appropriate weight in the cigarette design process.
The tobacco companies have deliberately made their products even
more addictive than they would be naturally. Ammonia is used to convert
naturally occurring nicotine to the free base form in order to enhance its
addictiveness. Additives such as menthol may also make cigarettes more
addictive by easing the ability to inhale smoke more deeply into the lungs.
Particle physicists working for the industry have designed aerodynamic
smoke particles that can reach the deepest cavities in the lungs. The FDA
needs unfettered authority to analyze the impact of cigarette ingredients
111: 1 (2002)
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and product design. This knowledge can then be used by the FDA to set
performance standards that will incrementally make the product less lethal
and less addictive.
Recent statements by several tobacco companies make clear that they
plan to develop what the industry characterizes as "reduced risk" cigarettes.
The proposed legislation will require manufacturers to submit such
"reduced risk" products to the FDA for analysis before they can be
marketed. No health-related claims will be permitted until they have been
verified to the FDA's satisfaction. These safeguards are essential to prevent
deceptive industry marketing campaigns, which could lull the public into a
false sense of health safety.
If the tobacco industry is permitted to market "reduced risk" products
without strict supervision by the FDA, the companies will heavily promote
minor product modifications that have no real impact on the health risks
posed to smokers. This was the case with "light" and "low tar" products,
presented in an earlier era as offering a safer way to smoke. Those claims
have now been conclusively disproved in a number of independent studies,
including one by the National Cancer Institute issued last year.
Unregulated claims of reduced risk can create the false perception
amongst smokers that they no longer need to quit and amongst non-
smokers that it is less dangerous to start.
Claims such as "reduced carcinogens" and "less of the toxins,"
currently appearing in advertisements for new products, imply much but
convey little actual information about the health risks. A reduction in the
level of one or two of the many different carcinogens present in cigarettes
may have only a negligible impact on the risk to the smoker of developing
cancer. Merely demonstrating a reduction in the level of one toxin does
not establish that the new product significantly reduces the overall health
risk. Only independent testing under FDA oversight can determine
whether a significant reduction in risk has actually been achieved. To be
genuinely "reduced risk," a tobacco product must demonstrate a
substantial net reduction in overall health risk to the public.
Congress must vest the FDA with not only the responsibility for
regulating tobacco products, but also with full authority to do the job
effectively. The proposed legislation will give the FDA the legal authority it
needs to (1) reduce youth smoking by preventing tobacco advertising
targeting children; (2) prevent the sale of tobacco products to minors; (3)
help smokers overcome their addiction; (4) make tobacco products less
toxic for those who continue to use them; and (5) prevent tobacco
companies from misleading the public about the dangers of smoking.
We cannot allow the tobacco industry to stop us from doing what we
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know is right for America's children. Empowering the nation's foremost
public health agency to regulate the consumer product posing the greatest
health hazard is long overdue. It will save thousands of lives each year.
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